Gigaxonin plays an integral role in the cellular machinery responsible for protein turnover, particularly through the ubiquitin-proteasome system. As an E3 ubiquitin ligase, gigaxonin targets specific proteins for ubiquitination, marking them for degradation by the proteasome. This function is critical in regulating the turnover of intermediate filaments (IFs), which are key components of the cytoskeleton providing structural support and playing roles in cell integrity and signal transmission. The precise control of IF protein levels by gigaxonin is essential for cellular homeostasis and has been shown to be particularly important in neuronal cells, where improper regulation of IFs can lead to neurodegenerative diseases. By facilitating the removal of damaged or excess IF proteins, gigaxonin helps maintain the dynamic balance of the cytoskeleton, ensuring cellular functionality and responsiveness to environmental cues.
The activation of gigaxonin involves several regulatory mechanisms that enhance its E3 ubiquitin ligase activity or increase its expression levels within the cell. One primary mechanism of activation could be through post-translational modifications of gigaxonin itself, such as phosphorylation, which may alter its conformation to a more active state or facilitate its interaction with substrate proteins. Additionally, signaling pathways that respond to cellular stress or damage may upregulate the expression of gigaxonin, as part of a broader cellular response to maintain protein homeostasis and protect against the accumulation of damaged proteins. The activation of gigaxonin could also be modulated by its interaction with other proteins within the ubiquitin-proteasome system, potentially enhancing its ability to target specific substrates for degradation. Understanding these activation mechanisms provides insights into how cells regulate protein turnover and maintain cellular health, highlighting the importance of gigaxonin in cellular dynamics and disease prevention.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin is a natural compound that activates Gigaxonin by inhibiting heat shock protein 90 (Hsp90). By blocking Hsp90, geldanamycin prevents the degradation of Gigaxonin and promotes its stability and activity. | ||||||
D-(+)-Trehalose Anhydrous | 99-20-7 | sc-294151 sc-294151A sc-294151B | 1 g 25 g 100 g | $30.00 $167.00 $260.00 | 2 | |
A disaccharide known to enhance autophagy. | ||||||
Clioquinol | 130-26-7 | sc-201066 sc-201066A | 1 g 5 g | $45.00 $115.00 | 2 | |
Clioquinol activates Gigaxonin by inhibiting zinc finger protein 1 (ZnF1), which leads to increased stability and activity of Gigaxonin. Clioquinol's inhibitory action on ZnF1 allows Gigaxonin to regulate protein degradation processes more efficiently. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, also known as calcimycin, activates Gigaxonin by inducing calcium influx. This increase in intracellular calcium levels enhances the binding of Gigaxonin to its target proteins, facilitating their degradation and maintaining protein homeostasis. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin activates Gigaxonin by inhibiting the sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) pump, leading to calcium release from the endoplasmic reticulum (ER). The elevated calcium levels stimulate Gigaxonin's activity in protein degradation pathways, ensuring proper protein turnover. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $94.00 $355.00 | 46 | |
An uncoupling agent that can activate autophagy. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates Gigaxonin by modulating the activity of sirtuins, which can enhance Gigaxonin-mediated protein degradation processes. Resveratrol's impact on sirtuins promotes the efficient regulation of protein homeostasis by Gigaxonin. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid activates Gigaxonin by inhibiting histone deacetylases (HDACs), which can modulate the expression of genes involved in protein homeostasis. By regulating gene expression, valproic acid enhances Gigaxonin-mediated protein degradation processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin activates Gigaxonin by inhibiting the mechanistic target of rapamycin (mTOR) pathway. By blocking mTOR, rapamycin promotes the activation of Gigaxonin and its role in protein degradation pathways. | ||||||